Shopping Cart
- Remove All
- Your shopping cart is currently empty
XmAb 5592 is a Fc-engineered and humanized anti-HM1.24 antibody with anti-tumor activity, used in the study of multiple myeloma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $183 | In Stock | |
5 mg | $496 | In Stock | |
10 mg | $795 | In Stock | |
25 mg | $1,180 | In Stock | |
50 mg | $1,580 | In Stock |
Description | XmAb 5592 is a Fc-engineered and humanized anti-HM1.24 antibody with anti-tumor activity, used in the study of multiple myeloma. |
Targets&IC50 | HM1.24:1.5 nM (Kd) |
In vitro | XmAb5592 binds to HM1.24 with high binding affinity and Kd value of 1.5 nM. XmAb 5592 enhanced antibody-dependent cytotoxicity (ADCC) and antibody-dependent cytophagocytosis (ADCP) against multiple myeloma (MM) cells at concentrations ranging from 0 to 1000 ng/mL. XmAb5592 significantly enhanced the cleavage of MM cell lines and significantly increased the maximum cleavage efficiency (EC50 range 5-27 ng/mL). [1] |
In vivo | SCID mice carrying RPMI8226 subcutaneous tumors were treated twice weekly with 0.9, 3.0, or 9.0 mg/kg of XmAb 5592, which inhibited RPMI8226 tumor growth in a dose-dependent manner. Its antitumor activity is mediated by an Fgamra-dependent mechanism. A single intravenous infusion of XmAb5592 at 20 mg/kg showed that a single dose of XmAb5592 depleted plasma cells in cymavores' blood and BM compartms. [1] |
Cas No. | 1221901-33-2 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.